Helicos to Cut 14 More Positions; Lapidus Steps Down as Chairman | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said Tuesday after the close of the market that as part of its ongoing restructuring plan it will cut another 14 positions from the firm as it aims to reduce its operating costs.

In addition, it disclosed that Chairman Stanley Lapidus has stepped down from his post but will remain a member of the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.